Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Thrombosis Journal|December 9, 2023
Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flowHiroaki Yaoi, Yasuaki Shida, Kenichi Ogiwara, et al.Thrombosis Research|November 28, 2020
Activated factor VIII-mimicking effect by emicizumab on thrombus formation in type 2N von Willebrand disease under high shear flow conditionsHiroaki Yaoi, Yasuaki Shida, Takehisa Kitazawa, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 8, 2021
Emicizumab improves thrombus formation of type 2A von willebrand disease under high shear conditionHiroaki Yaoi, Yasuaki Shida, Takehisa Kitazawa, et al.Thrombosis and Haemostasis|September 9, 2020
Emicizumab Augments Thrombus Formation in Whole Blood from Patients with Hemophilia A under High Shear Flow ConditionsHiroaki Yaoi, Yasuaki Shida, Takehisa Kitazawa, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|April 28, 2022
Emicizumab enhances thrombus formation in vitro under high shear flow conditions in whole blood from patients with type 1 and type 3 von Willebrand diseaseHiroaki Yaoi, Yasuaki Shida, Kenichi Ogiwara, et al.International Journal of Hematology|June 30, 2019
Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxisKoji Yada, Keiji Nogami, Kenichi Ogiwara, et al.Pageof 1